ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of SIMPONI® to Arrest Beta-cell Loss in Type 1 Diabetes (T1GER)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02846545
Recruitment Status : Active, not recruiting
First Posted : July 27, 2016
Last Update Posted : January 28, 2019
Sponsor:
Information provided by (Responsible Party):
Janssen Research & Development, LLC

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : February 2019
  Estimated Study Completion Date : May 2020